Machatha Stephen
SEC CIK 1836354 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ALDX | Aldeyra Therapeutics, Inc. | Chief Development Off | 221.8K | — | $324.8K | 6 | 2022-03-30 | 2025-08-11 |
Most active insiders at ALDX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Brady Todd C | Pres, CEO, Dir | $418.4K | — |
| 2 | DOUGLAS RICHARD | Dir | $98.0K | — |
| 3 | Alfieri Michael | Principal Financial Off | $7,100 | — |
Machatha Stephen made no open-market trades at ALDX in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-13 | 2025-08-11 | ALDX | Aldeyra Therapeutics, Inc. | Machatha Stephen | Chief Development Off | S - Sale | $5.15 | -22.1K | 221.8K | -9% | -$113.7K | |
| 2024-08-14 | 2024-08-12 | ALDX | Aldeyra Therapeutics, Inc. | Machatha Stephen | Chief Development Off | S - Sale | $4.74 | -16.0K | 236.8K | -6% | -$76.0K | |
| A | 2024-04-17 | 2024-03-12 | ALDX | Aldeyra Therapeutics, Inc. | Machatha Stephen | Chief Development Off | S - Sale | $3.16 | -11.5K | 252.8K | -4% | -$36.5K |
| DM | 2024-03-12 | 2024-03-11+ | ALDX | Aldeyra Therapeutics, Inc. | Machatha Stephen | Chief Development Off | S - Sale | $3.31 | -29.8K | 255.0K | -10% | -$98.6K |
| D | 2022-07-19 | 2022-07-15 | ALDX | Aldeyra Therapeutics, Inc. | Machatha Stephen | Chief Development Off | A - Grant | $0.00 | +185.6K | 273.3K | +212% | $0 |
| D | 2022-04-01 | 2022-03-30 | ALDX | Aldeyra Therapeutics, Inc. | Machatha Stephen | Chief Development Off | A - Grant | $0.00 | +64.4K | 87.7K | +277% | $0 |
Purchase Sale Sale after option exercise All abbreviations